| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 95041 |
丙炔基甘氨酸(PAG) |
537 |
WYQ |
2024-11-21 |
| 95042 |
5-碘甲基降冰片烯 , IMNB |
267 |
kx |
2024-11-21 |
| 95043 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
180 |
zyl |
2024-11-21 |
| 95044 |
DOTA-E[CYCLO(RGDFK)]2探针多肽 |
218 |
wyh |
2024-11-21 |
| 95045 |
DOTA-JR-11,1039726-31-2,放射显影多肽 |
184 |
zyl |
2024-11-21 |
| 95046 |
5-降冰片烯-2-亚甲基环氧丙基醚 , NB-MGE |
188 |
kx |
2024-11-21 |
| 95047 |
DO3A-Thiol ;CAS:865470-67-3 DOTA-SH |
178 |
wyh |
2024-11-21 |
| 95048 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
200 |
zyl |
2024-11-21 |
| 95049 |
Gd-DOTA-HCBP的组成结构 |
204 |
wyh |
2024-11-21 |
| 95050 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 , NB-O-Im+Br--Im+Br- |
228 |
kx |
2024-11-21 |
| 95051 |
479081-06-6 ;DOTA-(COOt-Bu)3-NHFmoc-Lys |
190 |
wyh |
2024-11-21 |
| 95052 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
174 |
zyl |
2024-11-21 |
| 95053 |
DOTA-octreotide的组成与结构 |
215 |
wyh |
2024-11-21 |
| 95054 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺, endo-PTNDI |
191 |
kx |
2024-11-21 |
| 95055 |
DOTA-Octreotide 大环配体奥曲肽 |
248 |
zyl |
2024-11-21 |
| 95056 |
端丙炔基聚乙二醇(PTPEG) |
233 |
WYQ |
2024-11-21 |
| 95057 |
CAS:127985-74-4,DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
184 |
wyh |
2024-11-21 |
| 95058 |
降冰片烯-异戊二烯共聚物 ,NBE-IP |
272 |
kx |
2024-11-21 |
| 95059 |
cyclo(RGDFK(DOTA))的特性与功能 |
178 |
wyh |
2024-11-21 |
| 95060 |
DOTA-cyclo(RGDfK) |
165 |
zyl |
2024-11-21 |
| 95061 |
Lu-DOTA-TATE;镥-大环配体-TATE多肽 |
570 |
wyh |
2024-11-21 |
| 95062 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 , endo-NDDE |
219 |
kx |
2024-11-21 |
| 95063 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
171 |
zyl |
2024-11-21 |
| 95064 |
DOTA-PEG-CPP;大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
208 |
wyh |
2024-11-21 |
| 95065 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
245 |
zyl |
2024-11-21 |
| 95066 |
DOTA-E「cyclo(RGDfK)2 |
177 |
wyh |
2024-11-21 |
| 95067 |
DOTA-(Tyr3)-Octreotate;大环配体修饰多肽 |
204 |
wyh |
2024-11-21 |
| 95068 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-磺酸基-β-CD(PMA-sulfated-β-CD) |
201 |
WYQ |
2024-11-21 |
| 95069 |
碘丙炔基正丁氨基甲酸酯(IPBC) |
397 |
WYQ |
2024-11-21 |
| 95070 |
Gd-DOTA-多肽 |
182 |
zyl |
2024-11-21 |
| 95071 |
DSPE-PEG-DOTA ;二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
509 |
wyh |
2024-11-21 |
| 95072 |
250612-06-7 ;DOTA-RGDfK dimer |
191 |
wyh |
2024-11-21 |
| 95073 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
282 |
zyl |
2024-11-21 |
| 95074 |
250612-06-7 DOTA多肽探针二聚体 |
164 |
wyh |
2024-11-21 |
| 95075 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
200 |
zyl |
2024-11-21 |
| 95076 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
176 |
wyh |
2024-11-21 |
| 95077 |
DOTA-NOC ;619300-53-7 |
166 |
wyh |
2024-11-21 |
| 95078 |
DOTA-奥曲肽,DOTA-Octreotide |
228 |
zyl |
2024-11-21 |
| 95079 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
172 |
wyh |
2024-11-21 |
| 95080 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
153 |
zyl |
2024-11-21 |
| 95081 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
161 |
wyh |
2024-11-21 |
| 95082 |
DOTA-RGD,DOTA-cRGDfK |
230 |
zyl |
2024-11-21 |
| 95083 |
DOTA-Lys-Cys-Acid 二肽DOTA-Lys-Cys |
189 |
wyh |
2024-11-21 |
| 95084 |
DOTA-Ala-Ala-COOH ;DOTA-丙氨酸-丙氨酸-羧酸 |
192 |
wyh |
2024-11-21 |
| 95085 |
cas:1293368-74-7,DOTA标记的多肽 |
202 |
zyl |
2024-11-21 |